Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone in FUS-Related ALS
NCT03707795Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, single-blind trial of betamethasone in familial amyotrophic lateral sclerosis (FALS) (2 arms). Primary endpoint: Betamethasone plasma levels at 14 days. Started Aug 2017; status: completed.
02
Drugs
betamethasone
03
Conditions
familial amyotrophic lateral sclerosis (FALS)
Beyond the preview
Go deeper on NCT03707795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707795.